Logo

American Heart Association

  120
  0


Final ID: We097

Dual Targeting CXCR4 and CXCR7 Prevents Doxorubicin-Induced Cardiotoxicity by Eliminating Cardiac Inflammation and Preserving Cardiomyocyte Function

Abstract Body: Background: Doxorubicin (DOX)-induced cardiotoxicity (DICT) has become a serious health burden for cancer survivors. The detrimental effects of CXCR4-mediated excessive inflammation in myocardium and the protective effects of CXCR7 in cardiomyocytes have been demonstrated.
Aims: We tested the protective effects against DICT of a dual-targeting compound TC14012, which has specific antagonistic activity against CXCR4 and potent agonistic activity on CXCR7.
Methods: Eight-week-old male C57BL/6J mice were injected with DOX for consecutive 5 weeks, during which mice were treated with TC14012 twice a week. One week after the last dose injection, mice were euthanized after heart function examination. Markers of cardiac inflammation and fibrosis were evaluated. Cardiac RNA-seq was performed to explore the underlying molecular pathways.
Key findings: TC14012 supplement significantly prevented DOX-induced cardiac systolic dysfunction, reflected by improved ejection fraction and fraction shortening, along with remarkable attenuation of DOX-induced cardiac perivascular and interstitial collagen deposition and neutrophils and macrophage infiltration. RNA-seq revealed that TC14012 prevention of DICT was accompanied with a remarkable stimulation of signals involving in cardiac contraction and energy reserve metabolic process, particularly glycogen and glucan metabolism that are crucial for meeting the cardiac energy demand in response to DOX induction. These signals could be further enriched into AMPK signaling pathway and validated by upregulation of AMPK phosphorylation. Besides, TC14012 prevention of DICT was accompanied with a significant reduction in cardiac mast cell activation and degranulation. These signals could be further enriched into Rap1 signaling pathway, and TC14012 was validated to inhibit Rap1 activity and mast cell activation. Most importantly, TC14012 treatment did not affect the suppressive effects of DOX on tumor growth in a syngeneic EL4 lymphoma-bearing, immunocompetent mouse model.
Conclusions: We preliminary conclude that TC14012 prevents DICT by activating cardiac CXCR7 to reprogram cardiomyocyte metabolism and prevent cardiac damage and dysfunction via activating AMPK, and by antagonizing CXCR4 to inhibit cardiac mast cell infiltration and activation via blunting Rap1 activity but does not affect the anti-tumor activity of DOX.
  • Hui, Xiaodan  ( University of Louisville , Louisville , Kentucky , United States )
  • Tan, Yi  ( University of Louisville , Louisville , Kentucky , United States )
  • Gu, Chunjie  ( University of Louisville , Louisville , Kentucky , United States )
  • Abdelbaset-ismail, Ahmed  ( University of Louisville , Louisville , Kentucky , United States )
  • Xu, Jianxiang  ( University of Louisville , Louisville , Kentucky , United States )
  • Tse, William  ( University of Louisville , Louisville , Kentucky , United States )
  • Raj, Ashok  ( Norton Children’s Hospital , Louisville , Kentucky , United States )
  • Deng, Zhongbin  ( University of Louisville , Louisville , Kentucky , United States )
  • Zhu, Wuqiang  ( Mayo Clinic , Scottsdale , Arizona , United States )
  • Cai, Lu  ( University of Louisville , Louisville , Kentucky , United States )
  • Author Disclosures:
    Xiaodan Hui: DO NOT have relevant financial relationships | Yi Tan: DO NOT have relevant financial relationships | Chunjie Gu: No Answer | Ahmed Abdelbaset-Ismail: No Answer | Jianxiang Xu: No Answer | William Tse: No Answer | Ashok Raj: No Answer | Zhongbin Deng: No Answer | Wuqiang Zhu: No Answer | Lu Cai: No Answer
Meeting Info:

Basic Cardiovascular Sciences

2024

Chicago, Illinois

Session Info:

Poster Session and Reception 3

Wednesday, 07/24/2024 , 04:30PM - 07:00PM

Poster Session and Reception

More abstracts on this topic:
Analysis of C-reactive protein omics-measures associates methylation risk score with obstructive sleep apnea-related measures

Wang Ziqing, Hou Lifang, Ramos Alberto, Kaur Sonya, Durda Peter, Gonzalez Hector, Fornage Myriam, Redline Susan, Isasi Carmen, Sofer Tamar, Wallace Danielle, Spitzer Brian, Huang Tianyi, Taylor Kent, Rotter Jerome, Rich Stephen, Liu Peter, Daviglus Martha

A Selective Agonist of the Beta 2 Retinoic Acid Receptor Reduces Necrosis, Lipid Peroxidation, and Oxidative Stress in Doxorubicin-induced Cardiotoxicity

Varzideh Fahimeh, Jankauskas Stanislovas, Kansakar Urna, Tang Xiao-han, Gudas Lorraine, Levi Roberto, Gambardella Jessica, Santulli Gaetano

More abstracts from these authors:
Dual CXCR4/CXCR7 Modulation: TC14012 as a Novel Therapeutic Strategy Against Doxorubicin-Induced Cardiotoxicity

Hui Xiaodan, Tan Yi, Gu Chunjie, Abdelbaset-ismail Ahmed, Xu Jianxiang, Tse William, Raj Ashok, Zhu Wuqiang, Deng Zhongbin, Cai Lu

Identification of CircRNA-miRNA-mRNA Regulatory Network and Crucial Signaling Pathways Related to Cardiomyocyte Proliferation in Neonatal Mice

Tang Ling, Nyarige Verah, Li Pengsheng, Zhu Wuqiang

You have to be authorized to contact abstract author. Please, Login
Not Available